# DOBUTAMINE

NDC: 51662-1330
Generic name: DOBUTAMINE
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190407

FDA application: NDA020201

## Active ingredients

- DOBUTAMINE HYDROCHLORIDE: 200 mg/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1330"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1330
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=85fb5ba6-3597-e09f-e053-2a91aa0aded5